Key stats
Market capitalization
2.591BUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−8.98USD
About Sage Therapeutics, Inc
ISIN
US78667J1088
Sector
Health Technology
Industry
Pharmaceuticals: Major
Website
sagerx.com
CEO
Barry E. Greene
Headquarters
Cambridge
Employees
689
Founded
2010
SAGE Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel medicines. It targets diseases and disorders of the brain with three key focus areas: depression, neurology, and neuropsychiatry. The company was founded by Steven Marc Paul and Douglas Covey on April 16, 2010, and is headquartered in Cambridge, MA.
Income Statement
Balance Sheet
Cash Flow
Earnings
Next:—
0
Revenue
0